Bruce A. Leicher

2016 - Momenta Pharmaceuticals

In 2016, Bruce A. Leicher earned a total compensation of $1.6M as Senior Vice President, General Counsel and Secretary at Momenta Pharmaceuticals, a 11% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$193,126
Option Awards$200,265
Salary$414,655
Stock Awards$771,993
Other$12,998
Total$1,593,037

Leicher received $772K in stock awards, accounting for 48% of the total pay in 2016.

Leicher also received $193.1K in non-equity incentive plan, $200.3K in option awards, $414.7K in salary and $13K in other compensation.

Rankings

In 2016, Bruce A. Leicher's compensation ranked 5,955th out of 14,075 executives tracked by ExecPay. In other words, Leicher earned more than 57.7% of executives.

ClassificationRankingPercentile
All
5,955
out of 14,075
58th
Division
Manufacturing
2,159
out of 5,486
61st
Major group
Chemicals And Allied Products
709
out of 1,900
63rd
Industry group
Drugs
534
out of 1,543
65th
Industry
Biological Products, Except Diagnostic Substances
100
out of 287
65th
Source: SEC filing on April 27, 2017.

Leicher's colleagues

We found five more compensation records of executives who worked with Bruce A. Leicher at Momenta Pharmaceuticals in 2016.

2016

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2016

Scott Storer

Momenta Pharmaceuticals

Chief Financial Officer

2016

Ganesh Kaundinya

Momenta Pharmaceuticals

Chief Scientific Officer

2016

Matthew Ottmer

Momenta Pharmaceuticals

Chief Operating Officer

2016

Richard Shea

Momenta Pharmaceuticals

Chief Financial Officer

You may also like